
Evidence analysis
Notice to sponsors on validation and qualification of computerised systems used in clinical trials
Notice to sponsors on validation and qualification of computerised systems used in clinical trials Date: 28 October 2026 What is established Validation and qualification of computerised systems are critical components in the conduct of clinical trials to ensure…
Read →
Evidence analysis
Veterinary medicines European public assessment report (EPAR): Cirbloc, porcine circovirus vaccine (inactivated), Status: Authorised
Health & Science Evidence Dossier: Cirbloc Porcine Circovirus Vaccine (Inactivated) What is established The European Medicines Agency (EMA) has authorised a veterinary medicinal product named Cirbloc, which is an inactivated vaccine developed to protect pigs against porcine circovirus…
Read →
Evidence analysis
Quarterly System Demo – Q4 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 December 2026, 09:00 (CET) to 10 December 2026, 12:30 (CET)
European Medicines Agency Quarterly System Demo – Q4 2026: An Evidence Analysis On 10 December 2026, the European Medicines Agency (EMA) held its 20th Quarterly System Demo, marking the final event of the year for its Agile Network…
Read →
Evidence analysis
Country report: ECDC Public Health Emergency Preparedness Assessment for Norway, 2025 – Under Article 8 of the Regulation (EU) 2022/2371
Evidence Dossier: Norway’s Public Health Emergency Preparedness Assessment 2025 What is established In 2025, the European Centre for Disease Prevention and Control (ECDC) conducted a comprehensive Public Health Emergency Preparedness Assessment for Norway. This assessment was part of…
Read →
Evidence analysis
Multi-model assessment of the impact of newborn RSV immunisation on hospitalisation burden in the EU/EEA
What is Established Respiratory Syncytial Virus (RSV) is recognized as a leading cause of respiratory infections across Europe, particularly affecting vulnerable groups such as young children, older adults, and people with underlying health conditions. In the EU/EEA region,…
Read →
Source briefing
Lawyers for ‘King of the South’ Try to Chip Away at U.S. Drug Trafficking Case
Lawyers for alleged drug capo Sebastián Marset have challenged the DEA’s search of a phone that was seized in uncertain circumstances in Bolivia. Marset’s defense team argues the phone only became part of the court records months after…
Read →
Evidence analysis
China Sentences Ex Anti-Graft Official to Suspended Death for Bribery
Accountability and Corruption: The Case of Wang Huimin in China What is established A Chinese court sentenced Wang Huimin, a former senior official at the China Securities Regulatory Commission (CSRC), to a suspended death sentence for accepting bribes…
Read →
Evidence analysis
Flávio Bolsonaro Flees Brazil After Election Defeat and Amid Fraud Probes
Accountability: Flávio Bolsonaro Flees Brazil Amid Fraud Probes Accountability: Flávio Bolsonaro Flees Brazil Amid Fraud Probes This dossier reviews facts and claims reported by the Organized Crime and Corruption Reporting Project (OCCRP) on October 28, 2026, concerning Brazilian…
Read →
Evidence analysis
As the cold season nears, immunisation of newborns against universal RSV could significantly reduce infant hospitalisations across Europe
What is established Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infection among infants, particularly during the autumn and winter months in Europe. Hospitalisations of young children, especially newborns, commonly increase during this period due…
Read →
Evidence analysis
Syria's New Reconstruction Fund a Chance for Reform
What is established As of October 18, 2026, the Syrian government and the World Bank Group have jointly announced the creation of the Syria Recovery and Reconstruction Trust Fund (START), a reconstruction fund managed by the World Bank.…
Read →